Special article
Consensus on improving the comprehensive care of patients with acute heart failureConsenso para la mejora de la atención integral de los pacientes con insuficiencia cardíaca aguda

https://doi.org/10.1016/j.rceng.2020.12.001Get rights and content

Abstract

The latest acute heart failure (AHF) consensus document from the Spanish Society of Cardiology (SEC, for its initials in Spanish), Spanish Society of Internal Medicine (SEMI), and Spanish Society of Emergency Medicine (SEMES) was published in 2015, which made an update covering the main novelties regarding AHF from the last few years necessary. These include publication of updated European guidelines on HF in 2016, new studies on the pharmacological treatment of patients during hospitalization, and other recent developments regarding AHF such as early treatment, intermittent treatment, advanced HF, and refractory congestion. This consensus document was drafted with the aim of updating all aspects related to AHF and to create a document that comprehensively describes the diagnosis, treatment, and management of this disease.

Resumen

El último consenso sobre insuficiencia cardíaca aguda de la Sociedad Española de Cardiología, la Sociedad Española de Medicina Interna y la Sociedad Española de Medicina de Urgencias y Emergencias fue realizado en 2015, por lo que era necesaria una actualización para revisar las diversas novedades relacionadas con la temática del ICA que han ido apareciendo los últimos años. Entre ellas están la publicación de las nuevas guías europeas sobre IC en el 2016, nuevos estudios sobre el manejo farmacológico de los pacientes durante la hospitalización, y novedades sobre diversos aspectos relacionados con la ICA tales como el abordaje precoz, terapia intermitente, IC avanzada, y congestión refractaria. Por ello, este consenso se realizó con la intención de actualizar todos los aspectos relacionados con la ICA y proporcionar un documento que detalle de manera comprensiva el diagnóstico, tratamiento y manejo de esta enfermedad.

Introduction

The latest acute heart failure (AHF) consensus document from the Spanish Society of Cardiology (SEC, for its initials in Spanish), Spanish Society of Internal Medicine (SEMI, for its initials in Spanish), and Spanish Society of Emergency Medicine (SEMES, for its initials in Spanish) was published in 2015. Therefore, an update reviewing the various novelties regarding AHF that have emerged in recent years is necessary. These include the publication of new studies on the pharmacological treatment of patients with AHF during hospitalization and other recent developments such as early treatment, intermittent treatment, advanced heart failure, and refractory congestion. This consensus document was created with the aim of updating these aspects and creating a practical document that comprehensively describes the diagnosis, treatment, and management of this disease.

This document is an abridged version of the consensus document and describes the most essential parts of each section.

Section snippets

Methods

In order to create this document, a committee of coordinators who represent each of the three societies involved was formed and the following methodology was established:

  • 1)

    A bibliographic search for each section of the document principally using the MEDLINE and Embase databases and searching for relevant articles in the period from January 2015 to February 2019. The types of articles were, preferentially, randomized clinical trials, reviews, meta-analyses, consensus documents and guidelines, and

Funding

Novartis Farmacéutica S.A. provided financial support for this project. However, the development, interpretation of data, opinions, and drafting of this study have been carried out exclusively by the investigators.

Conflicts of interest

Dr. Juan F. Delgado receives fees for consulting or speaking from Novartis, AstraZeneca, Rovi, Medtronic, Abbott, Vifor, Amgen, Orion Pharma, and Impulse Dynamics.

Dr. Francesc Formiga has received fees for consulting, conferences, and attendance of congresses from Novartis and Rovi and consulting fees from Vifor and Pfizer.

Dr. Esteban López de Sá receives fees from Becton Dickinson, ZOLL Circulation, Boehringer Ingelheim, Daiichi Sankyo, and Ferrer.

Dr. Josep Masip receives fees for conferences

References (18)

There are more references available in the full text version of this article.

Cited by (0)

Please cite this article as: Delgado JF, Cepeda JM, Llorens P, Jacob J, Comín J, Montero M et al. Consenso para la mejora de la atención integral de los pacientes con insuficiencia cardíaca aguda. Rev Clin Esp. 2021;221:163–168.

View full text